We don’t just guess how a tumor might respond to drugs – we see those responses in living patient cells on our platform. Our machine learning-based sensitivity assay, paired with -omics data, allows us to identify predictive biomarkers and the most likely responders for any new drug.
Known Medicine was founded on the premise that breakthroughs require collaboration from multidisciplinary technical experts. Every technical teammate, from scientists to software engineers, collaborates in designing our dataset and deciphering our results.
Each experiment we run makes us better for the next patient. We are building the world’s largest purpose-built 3D cell culture dataset with millions of images of patient cancer cells responding to hundreds of drugs and combinations.